| [1] | Bray F., Laversanne M., Sung H., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74:229−263. DOI:10.3322/caac.21834 |
| [2] | Buys S. S., Partridge E., Black A., et al. (2011). Effect of screening on ovarian cancer mortality: The prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 305:2295−2303. DOI:10.1001/jama.2011.766 |
| [3] | Menon U., Gentry-Maharaj A., Burnell M., et al. (2021). Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A randomised controlled trial. Lancet 397:2182−2193. DOI:10.1016/s0140-6736(21)00731-5 |
| [4] | Hu X., Zhang J. and Cao Y. (2022). Factors associated with serum CA125 level in women without ovarian cancer in the United States: A population-based study. BMC Cancer 22:544. DOI:10.1186/s12885-022-09637-7 |
| [5] | Sasamoto N., Babic A., Rosner B. A., et al. (2019). Development and validation of circulating CA125 prediction models in postmenopausal women. J. Ovarian Res. 12:116. DOI:10.1186/s13048-019-0591-4 |
| [6] | Davis S. R. and Baber R. J. (2022). Treating menopause - MHT and beyond. Nat. Rev. Endocrinol. 18:490−502. DOI:10.1038/s41574-022-00685-4 |
| [7] | Chen W., Liu H., Huang X., et al. (2023). A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites. iScience 26:107712. DOI:10.1016/j.isci.2023.107712 |
| [8] | Nunez J., de la Espriella R., Minana G., et al. (2021). Antigen carbohydrate 125 as a biomarker in heart failure: A narrative review. Eur. J. Heart Fail. 23:1445−1457. DOI:10.1002/ejhf.2295 |
| [9] | Sadowski E. A., Thomassin-Naggara I., Rockall A., et al. (2022). O-RADS MRI risk stratification system: Guide for assessing adnexal lesions from the ACR O-RADS committee. Radiology 303:35−47. DOI:10.1148/radiol.204371 |
| [10] | Santoro N., Epperson C. N. and Mathews S. B. (2015). Menopausal symptoms and their management. Endocrinol. Metab. Clin. North Am. 44:497−515. DOI:10.1016/j.ecl.2015.05.001 |
| Zhu C., Liu X., Xu H., et al. (2025). A cross-sectional study of 55,415 women validating the effect of age on serum CA125 levels. The Innovation Medicine 3:100147. https://doi.org/10.59717/j.xinn-med.2025.100147 |
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Analysis of distribution, variation, and trends in CA125 levels across age groups among 55,415 Women